Referral Network Addendum

This Referral Network Addendum (this "Addendum") applies when the organization accepting it ("Customer") uses the Lumagen service to refer a patient to a genetic counseling provider. This Addendum supplements Customer's agreement with Helix Reserve LLC, doing business as Lumagen ("Lumagen"), and the Business Associate Agreement between them (the "BAA").

1. Referral Decisions

Customer's clinicians determine, in their independent professional judgment, whether and to whom to refer a patient. Customer may refer to any provider, within or outside Lumagen's network, and a patient may select a different provider at any time. Nothing in the Lumagen service requires a referral to any provider.

2. Network Partners

Lumagen may display network partners by state. Customer selects any network partner it uses and may change or remove that partner at any time. Customer is responsible for confirming, before each referral, that the provider is appropriate for the patient and is able to serve the patient at the patient's location.

3. Role of Lumagen

Lumagen is a technology provider. It does not render medical care or genetic counseling, does not supervise any provider, and is not responsible for the care any provider renders. "Preferred" signifies only that a partner has executed Lumagen's partner agreement and that Lumagen has reviewed its license and insurance documentation. It is not an endorsement of, or a guarantee as to the quality of, any provider's care.

4. Commercial Relationships

Lumagen has commercial relationships with certain network partners, which may include a partner's use of Lumagen software at no charge or a reduced price, and Lumagen's payment to a partner of a share of subscription revenue from clinics the partner introduces to Lumagen. Lumagen neither pays nor receives remuneration for any referral, and Customer receives no remuneration for referring any patient.

5. Authorization to Disclose

5.1 Authorization. By sending a referral, Customer directs Lumagen to disclose to the selected provider, for the patient's treatment, the referral information for that patient, including contact details, family history, and criteria results. Customer further directs Lumagen to receive from that provider, and display in Customer's record, referral status, testing decisions, and results. Each such disclosure is permitted under Section 1.1 of the BAA.

5.2 Provider Records. Information a provider copies into its own account is the provider's record and not Customer's.

5.3 Customer Responsibility. Customer is responsible for all notices, consents, and authorizations required by applicable law for such disclosures, including under state genetic privacy laws.

6. Arrangements with Providers

Lumagen is not a party to any arrangement between Customer and a provider. Any payment by Customer to a provider requires a separate agreement between them. Providers bill patients and payers under their own terms.

7. General Provisions

7.1 No Third-Party Beneficiaries. This Addendum confers no rights on any patient or other third party.

7.2 Corporate Reorganization. A conversion, domestication, reincorporation, or reorganization of Lumagen, a change in its entity type, jurisdiction of organization, or name, and a merger with or transfer to an entity formed for that purpose or under common control with Lumagen is not an assignment and requires no consent. Upon any such event, this Addendum, Customer's agreement with Lumagen, the BAA, and every other agreement between the parties remain in full force with the resulting entity. Lumagen shall give Customer notice within thirty (30) days after the event takes effect.

7.3 Precedence. The BAA controls over Section 5 in the event of conflict.